Language
  • English (US)
  • Français
  • Portuguese (Portugal)
  • Information on health systems and national procurement prices related to cardiometabolic medicines, diagnostics, and technologies

    Information on health systems and national procurement prices related to cardiometabolic medicines, diagnostics, and technologies

  • Background

    The WHO Regional Office for Africa is conducting a regional assessment on the availability and prices of essential medicines, diagnostics, and technologies for cardiometabolic conditions—specifically type 1 and 2 diabetes and cardiovascular diseases such as hypertension, myocardial infarction, cardiovascular episodes, and atherosclerotic cardiovascular disease—in the WHO African Region. The objective is to identify barriers and inform targeted interventions to improve availability, affordability, and equitable access.

    The assessment includes three key components:

    1.     Facility-level surveys using an app-based tool to collect data on price and availability in public and private health facilities.

    2.     Procurement analysis to gather contextual information on health systems and national procurement prices.

    3.     Price component tracking to examine the breakdown of medicine costs across the supply chain.

    Together, these elements will provide a comprehensive understanding of both facility-level access and systemic bottlenecks affecting supply and policy.

  • Purpose

    This online survey focuses on Component 2: Procurement analysis. It aims to gather information on health system policies and practices, and national procurement prices related to cardiometabolic medicines, diagnostics, and technologies. The goal is to better understand each country’s capacity to ensure access to essential resources for managing cardiometabolic conditions.

    The survey has two parts: 

    ·       Part A: Health System Questions – covering policies and procedures that support access to essential resources for managing cardiometabolic conditions.

    ·       Part B: Government Procurement – focusing on pricing and procurement of relevant medicines and technologies. 

    You can navigate these parts in the tabs above. 

     

  • A national focal point is designated to oversee completion of this survey. To ensure comprehensive responses, input from multiple experts familiar with the topics covered is recommended. 

    On the next page, you add contact information for both the national focal point and others who will be completing the survey, and see the instructions for completing the survey. Please read the instructions completely prior to continuing the survey.

     

  • INFORMATION ON RESPONDENTS

  • INSTRUCTIONS FOR LEAD FOCAL POINTS- Please first take time to review the entire survey to understand what information is required. When you are ready, please include in this section your full name, title and email. Then also input all of the names of the colleagues you will need to contact to support the completion of this survey. When you have filled out this page completely click on the "Contact Information Complete" button. 

     You will then receive email version of the survey in the inbox of the email you provided. At the top of this email you will see an  "Edit Form" button at the top of the email. 

     

     

    You can then forward this version of the survey to others listed as "additional support contacts" so that they can complete their sections of the survey. Whenever your additional contacts have submitted a section, you will receive an email.  When all of the sections are complete you must hit "submit final survey" on the last page. 

     

     

  • Lead Focal Point Contact Information

  • Additional Support Contacts

  • INSTRUCTIONS FOR ADDITIONAL CONTACTS- - Please fill out the sections that you have been assigned on this page by your Lead Focal Point. When you are done with your sections, click "Submit" on the final page you have completed. Your Lead Focal Point will then receive an email that your section has been completed and may follow up with additional information. 

  • Click "next" to begin the survey. 

    Please note that while there is space to indicate “Don’t know” for most questions, there should be very few of these. If someone is filling in numerous “Don’t knows”, another person who is more aware of this information should be found to complete this section.

    In order to validate responses, documentation will be requested for affirmative responses throughout the questionnaire. Please make every effort to provide electronic copies of the requested documentation, or provide online links.

  • A. HEALTH SYSTEM QUESTIONS

    Section A. 1 Public health infrastructure

  • The questions are related to the presence of a unit or division in the ministry of health dedicated to NCD staff and funding.

    Please fill out the sections that you have been assigned by your Lead Focal Point. When you are done with your sections, click "Submit" on the final page you have completed. Your Lead Focal Point will then receive an email that your section has been completed and may follow up with additional information. 

  • Rows
  • Rows

  • Finished the sections you were assigned to complete? Please click on "Submit".  Have more sections to complete? Please click on "Next" 

  • A. HEALTH SYSTEM QUESTIONS

    Section A.2 Policies, strategies, action plans for specific key NCDs

  • The questions in this sub-section only refer to policies, strategies and action plans that are specific to key NCDs.

    Please fill out the sections that you have been assigned by your Lead Focal Point. When you are done with your sections, click "Submit" on the final page you have completed. Your Lead Focal Point will then receive an email that your section has been completed and may follow up with additional information.

  • Validation Documents

    Please share related policies, strategies or action plans here. Either upload documents, or share the weblink
  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof

  • Finished the sections you were assigned to complete? Please click on "Submit". Have more sections to complete? Please click on "Next"

  • A. HEALTH SYSTEM QUESTIONS

    Section A.3 Health information systems

  • Data included in the national health information system.
    Note: The national health information system refers to the annual or regular reporting system of the National Statistical Office or Ministry of Health.

    Please fill out the sections that you have been assigned by your Lead Focal Point. When you are done with your sections, click "Submit" on the final page you have completed. Your Lead Focal Point will then receive an email that your section has been completed and may follow up with additional information.

  • Validation Documents

    Please share related documents here. Either upload documents, or share the weblink
  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof

  • Finished the sections you were assigned to complete? Please click on "Submit". Have more sections to complete? Please click on "Next"

  • A. HEALTH SYSTEM QUESTIONS

    Section A.4 Capacity for diagnosis, treatment and care within the health system

  • The questions in this module assess the health care system's capacity related to NCD early detection, treatment, and care within the health care sector. Specific questions focus on the availability of guidelines or protocols.

    Please fill out the sections that you have been assigned by your Lead Focal Point. When you are done with your sections, click "Submit" on the final page you have completed. Your Lead Focal Point will then receive an email that your section has been completed and may follow up with additional information.

  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof
  • Rows
  • Rows
  • Rows

  • Validation Documents

    Please share related documents here. Either upload documents, or share the weblink
  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof

  • Finished the sections you were assigned to complete? Please click on "Submit". Have more sections to complete? Please click on "Next"

  • A. HEALTH SYSTEM QUESTIONS

    A.5 Availability and Prices of Medicines

  • Please fill out the sections that you have been assigned by your Lead Focal Point. When you are done with your sections, click "Submit" on the final page you have completed. Your Lead Focal Point will then receive an email that your section has been completed and may follow up with additional information.

  • Rows
  • Rows

  • Finished the sections you were assigned to complete? Please click on "Submit". Have more sections to complete? Please click on "Next"

  • B. GOVERNMENT PROCUREMENT PRICES

  • Please fill out the sections that you have been assigned by your Lead Focal Point. When you are done with your sections, click "Submit" on the final page you have completed. Your Lead Focal Point will then receive an email that your section has been completed and may follow up with additional information.

  • Collecting and analysing government procurement prices will help to better understand medicine and technology prices across the supply chain. For the procurement price collection, please ask an informant working in procurement to complete the below forms relating to the following medicines.

    Insulin and Delivery Devices

    Cardiovascular Medicines (hypertension, myocardial infarction, cardiovascular episodes, and atherosclerotic cardiovascular disease)

    Insulin - Regular, NPH and mixed regular/NPH human insulin, rapid-acting, long-acting and mixed analogue insulin in vials, pre-filled pens and cartridges
    Delivery devices - Insulin syringes and pen needles

    ACE inhibitors –  lisinopril, ramipril, perindopril, enalapril, captopril 
    Angiotensin receptor blockers – losartan, telmisartan, valsartan, 
    CCBs – nifedipine retard, amlodipine, nicardipine
    Diruectics –( Thiaziade & Thiazide-like Hydrochlorothiazide (HCTZ),Chlorthalidone,Chlorothiazide,Indapamide
    Loop diurectics -Torsemide, Furosemide, Bumetanide
    Potassium- Sparing -Spironolactone, Mannitol, Epleronone, Amiloride
    Antiplatelet - aspirin, clopidogrel
    Statins – simvastatin, atorvastatin, fluvastatin, lovastatin, pravastatin, rosuvastatin
    Beta blockers – atenolol, metoprolol, bisoprolol, carvedilol
    Vasodilators- hydrallazine 
    Anti-hypetension combinations: lisonipril+amlodipine, lisonipril+hydrochlorothiazide, perindopril+amlodipine+indapamide, telmisartan+amlodipine, telmisartan+ hydrochlorothiazide, valsartan+amlodipine+hydrochlorothiazide
    Methyldopa
    Diabetes and Sickle Cell Medicines Diagnostic Devices 

    Metformin 
    Sulfonylurea - gliclazide, glimepiride, glipizide, glibenclamide
    Thiazilodines-pioglitazone 
    Gliptins-vildagliptin,sitagliptin 
    SLGT-2 – empagliflozin, dapagliflozin, canaglifozin
    GLP- 1 – semaglutide, dulaglutide, liraglutide, tirzepatide
    Hydroxycarbamide (hydroxyurea)-hydroxyurea, deferasirox, deferiprone

    Blood glucose meter and test strips
    Fasting plasma glucose machine
    HBA1c testing machine
    Blood pressure machine (Validated BP machine/Validated digital BP monitors) – indicating which cuff size availability included

     

     
     

  • To fill in the forms, please review the instructions by clicking on the instructions line below. Then enter medicine information within each of the four categories. 

    If you do not procure a specific type of medicine, please answer "no" to the first question about procurement per medicine category and move to the next. Please enter information for all brands of the medicines you procure. 

    • Instructions 

    • Note: For each medicine or technology we will ask that you include a new entry for each brand you procure.  Please do this by clicking the "click to add an additional" button at the end of each medicine entry. 


      Insulin/Medicine Type- For medicines, please indicate which type of medicine you have procured per category.  From insulin and devices, please select from the drop down list.  Repeat for each type/brand procured.
      Type of Devices - Please select from the list and repeat for each device procured. 
      Brand/trade name - Please include the full brand/trade name (e.g. Humulin N, Novolog Mix 70/30 etc.)
      Manufacturer - Please include the full name of the manufacturer
      Tender / purchase year(s) - Include the year in YYYY form. If the tender was for more than one year, please enter the data for the current year.  Strength - Please indicate the strength of medicine procured and please repeat for each strength of each medicine procured. For insulin, please select from the dropdown menu. 
      Presentation -(For insulin and GLP-1) please select from the drop down menu: vial, prefill pen or cartridge
      Number of mls per vial, prefilled pen or cartridge - For insulin, please indicate the volume of insulin per vial, pen, or cartridge (e.g. 3ml, 5ml, 10ml), for GLP-1 please include the volume per pen or cartridge. 
      Pack size - State how many vials, pen, cartridges,tablets or devices are in each pack
      Procurement price per pack - Indicate the price per pack. Enter only the number. In local currency
      Currency of purchase - currency of purchased goods
      Annual quantity procured - Indicate the total number of packs procured for the year
      Annual awarded quantity at no cost - if you receive any of these products as part of a donation program or other scheme, please indicate the amount here
      Pack selling price to facilities (in local currency) - if you know the selling price per pack please indicate here in local currency. If you do not know, leave it blank 
      Pack selling price directly to patients -  if you sell directly to patients, please indicate here in local currency. If you do not know, leave it blank 
      INCO term used in the transaction from your procurement form. You can select the INCO term from the drop down menu (definitions below)
      CFR — Cost and Freight
      DAT — Delivered at Terminal
      CIF — Cost, Insurance and Freight
      EXW — EX Works
      CIP — Carriage and Insurance Paid Тo
      FAS — Free Alongside Ship
      CPT — Carriage Paid To
      FCA — Free Carrier
      DAP  - Delivered at Place
      FOB — Free On Board
      DDP — Delivered Duty Paid
      Procurement methods -  Please select from the drop down which methods were used to procure this medicine. If it is other, please leave more details if you have them in the comments (Open Tender, Restricted Tender,  Emergency Procurement, Long term agreement (LTA), Local Purchase (wholesaler/pharmacy/other), Other)
      Were any national taxes included in this final price? Please select Yes, No or I don’t know.  If If yes, please indicate type and amount - 
      Reasons can't share price - If you are unable to share the procurement price of the product, please include reason here
      Comments- If you have further comments, please add them here.

    • Insulin and delivery devices 

    • Insulin

    • Delivery Devices

    • Cardiovascular Medicines 

    • ACE Inhibitors

    • Angiostensin receptor blockers

    • Calcium Channel Blockers

    • Diuretics

    • Antiplatelets

    • Vasodilators

    • Statins

    • Beta Blockers

    • Anti-hypertension combinations

    • Diabetes and Sickle Cell Medicines 

    • Metformin

    • Sulfonylureas

    • Thiazilodines

    • Gliptins

    • SLGT-2

    • GLP-1

    • Sickle-cell disease

    • Diagnostic Devices  

    • Blood Glucose Self-Monitoring Devices

      Glucose meters, test strips and lancets

    • HbA1C (Hemoglobin Analyzer)Devices

    • Digital and Validated Blood Pressure Monitoring Device

    • Finished the sections you were assigned to complete? Please click on "Submit". Have more sections to complete? Please click on "Next"

  • Image field 307

  • Thank you very much for completing this important survey. We will be in touch with any questions or clarifications that might be neccesary.

    Please only click submit if you are the Lead Focal Point. Please double check all areas of the survey have been completed prior to clicking the "Submit Final" button.

  • Should be Empty: